ISSN: 2329-9053

Journal de recherche sur la pharmacie moléculaire et les processus organiques

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

DRUG MANAGEMENT ANALYSIS IN THE DEPARTEMENT OF PHARMACY HOSPITAL NACIONAL GUIDO VALADARES DILI TIMOR LESTE 2017

Santana Martins

The Department of Pharmacy is a part of the hospital that is responsible for managing drugs which includes the selection, procurement, distribution and use of drugs. This study aims to analyse the level of efficiency of drug management in the Pharmacy Department of Hospital Nacional Guido Valadares Dili.

Research uses descriptive designs for retrospective and concurrent data. Retrospective observations include planning and drug use reports, financial reports, drug procurement reports, invoices, stock taking reports. Concurrent observation includes the average waiting time for patient prescription services. Data is collected quantitatively and qualitatively. Data obtained from all stages of drug management in the Pharmacy Department of the Hospital National Guido Valadares Dili were analysed by efficiency indicators using the Ministry of Health indicators (2008) and WHO (1993) then compared with other standards or research results.

The results of the study show that the management system that is not yet in accordance with the standards is: the selection stage, the suitability of the drug with DOEN TL (96.19%); stage of procurement, capital / funds available with all the funds needed (86.03%); allocation of funds for drug procurement (4.23%); suitability of planning with the actual use for each drug item (88.12%); procurement of each drug item per year (4.97 times); distribution stage, drug expiration and damage (20.76%).